🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This first clinical study of 10-1074-LS will evaluate its safety, tolerabil...
Status
Completed
Location
The Rockefeller University
Start Date
2018-06-20
Trial ID
NCT03554408
Treatments Being Tested
Approximately 108 subjects will be randomized in 2 arms in 2:1 ratio to rec...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-15
Trial ID
NCT06590090
Treatments Being Tested
RATIONALE: Biological therapy using a gene-modified virus that can make int...
Status
Terminated
Location
Mount Sinai Medical Center
Start Date
2005-10
Trial ID
NCT00301106
Treatments Being Tested
The purpose of the study is to compare local pain experienced after subcuta...
Status
Completed
Location
Investigational Site
Start Date
2011-05
Trial ID
NCT01401764
Treatments Being Tested
This study is designed to explore the safety and tolerability of an investi...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01446926
Treatments Being Tested
HI-PAD is a placebo controlled double-blind randomized pilot clinical trial...
Status
Completed
Location
Northwestern University
Start Date
2018-01-01
Trial ID
NCT03363165
As \< 10% of the necessary patients required by the protocol were recruited...
Status
Terminated
Location
LAC-USC Medical Center
Start Date
2012-01
Trial ID
NCT01521143
The goal of this multi-centre, prospective, open label, single arm, observa...
Status
Completed
Location
bitop AG
Start Date
2021-05-03
Trial ID
NCT04910906
Treatments Being Tested
Head and neck squamous cell carcinoma (HNSCC) is the most common cancer ari...
Status
Terminated
Location
UPMC Presbyterian
Start Date
2015-09
Trial ID
NCT02277184
Treatments Being Tested
This phase 2 clinical trial will investigate an optimal dose, dosing regime...
Status
Active Not Recruiting
Location
Benchmark Research
Start Date
2025-03-10
Trial ID
NCT06899802
Treatments Being Tested